Clinical Trial Update: Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating bleomycin as sclerotherapy for pediatric lymphatic malformations; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphatic Malformation

Drugs mentioned

• Bleomycin (bleomycin)

Snippet

Sponsor: West China Hospital | Conditions: Lymphatic Malformation | Phase 2 | Status: RECRUITING